The Effect of CYP3A4 Inhibition or Induction on the Pharmacokinetics and Pharmacodynamics of Orally Administered Ruxolitinib (INCB018424 Phosphate) in Healthy Volunteers-Reference-Cited by-同舟云学术

The Effect of CYP3A4 Inhibition or Induction on the Pharmacokinetics and Pharmacodynamics of Orally Administered Ruxolitinib (INCB018424 Phosphate) in Healthy Volunteers

Published:2012-06 Issue:6 Volume:52 Page:809-818
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Shi Jack G.,Chen Xuejun,Emm Thomas,Scherle Peggy A.,McGee Ryan F.,Lo Yvonne,Landman Robert R.,McKeever Edward G.,Punwani Naresh G.,Williams William V.,Yeleswaram Swamy

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270011405663/fullpdf

Reference14 articles.

1. Janus kinases in immune cell signaling;Ghoreschi;Immunol Rev,2009

2. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

3. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis;Levine;Cancer Cell,2005

4. Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms;Quintás-Cardama;Blood,2010

5. Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis;Verstovsek;N Engl J Med,2010

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruxolitinib dosing for acute graft‐versus‐host disease in a pediatric patient receiving continuous renal replacement therapy;Pediatric Blood & Cancer;2023-10-30

2. Pharmacokinetics of baricitinib in critically ill COVID-19 patients;Clinical Biochemistry;2023-08

3. Tuberculosis and Hematological Malignancies: Real-world Experience and Key Insights into Drug–Drug Interactions;Journal of Clinical Infectious Disease Society;2023-07

4. Dose-escalating ruxolitinib for refractory hemophagocytic lymphohistiocytosis;Frontiers in Immunology;2023-06-29

5. Exploring the role of Janus kinase (JAK) in atopic dermatitis: a review of molecular mechanisms and therapeutic strategies;Immunological Medicine;2023-05-31